Molecular Discovery Program

分子发现计划

• 批准号: 8763470
• 负责人: Jeffrey Strathern
• 金额: $ 13.75万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8763470
• 关键词: Annual Reports; Basic Science; Biological Factors; Biological Process; Biology; Biophysics; CBL gene; CCR; Cancer Biology; Chemicals; Collaborations; Coupling; Development; Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis; Fostering; Goals; Laboratories; Libraries; Methodology; Molecular; Molecular Target; Process; Research; Research Activity; Research Personnel; Technology; Therapeutic; Translations; Validation; Vision; Work; cancer diagnosis; cancer therapy; drug development; new technology; novel; programs; screening; small molecule; small molecule libraries; structural biology

In FY2013, the MDP activities were limited to actions taken by Investigators in the participating Laboratories (Molecular Targets Laboratory - MTL, Chemical Biology Laboratory - CBL, and Structural Biophysics Laboratory - SBL). Investigators from the participating Laboratories served in the broader drug development program known as the NCI Experimental Therapeutics (NeXT) Discovery and Development Committees. The ongoing activities in the Molecular Targets Laboratory include some 12 projects aimed at screening the natural products library for active modulating compounds, as well as some defined chemical libraries. Research activities in the SBL and CBL will be described in their respective Laboratory annual reports.

在2013财年，MDP活动仅限于参与实验室中研究人员采取的行动（分子目标实验室-MTL，化学生物学实验室-CBL和结构性生物物理实验室-SBL）。参与实验室的研究人员在更广泛的药物开发计划中，称为NCI实验治疗剂（下一个）发现和开发委员会。分子目标实验室中正在进行的活动包括大约12个项目，旨在筛选天然产品库以进行主动调节化合物以及一些定义的化学文库。 SBL和CBL的研究活动将在其各自的实验室年度报告中进行描述。